Alan T Nguyen
Overview
Explore the profile of Alan T Nguyen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lau D, Wadhwa H, Sudhir S, Chang A, Jain S, Chandra A, et al.
JCI Insight
. 2021 May;
6(12).
PMID: 34003803
Metastases cause 90% of human cancer deaths. The metastatic cascade involves local invasion, intravasation, extravasation, metastatic site colonization, and proliferation. Although individual mediators of these processes have been investigated, interactions...
12.
Chandra A, Jahangiri A, Chen W, Nguyen A, Yagnik G, Pereira M, et al.
Cancer Res
. 2020 Feb;
80(7):1498-1511.
PMID: 32041837
Glioblastoma (GBM) responses to bevacizumab are invariably transient with acquired resistance. We profiled paired patient specimens and bevacizumab-resistant xenograft models pre- and post-resistance toward the primary goal of identifying regulators...
13.
Foster D, Nguyen A, Chinta M, Salhotra A, Jones R, Mascharak S, et al.
Sci Rep
. 2019 Nov;
9(1):15791.
PMID: 31673001
Fluorescent proteins are used extensively in transgenic animal models to label and study specific cell and tissue types. Expression of these proteins can be imaged and analyzed using fluorescent and...
14.
Rick J, Chandra A, Dalle Ore C, Nguyen A, Yagnik G, Aghi M
Semin Oncol
. 2019 Sep;
46(3):284-290.
PMID: 31488338
Initial studies on cancer primarily focused on malignant cells themselves. The overarching narrative of cancer revolved around unchecked and rapidly proliferating cells. Special attention was given to the molecular, genetic,...
15.
Chandra A, Young J, Dalle Ore C, Dayani F, Lau D, Wadhwa H, et al.
J Neurosurg
. 2019 Jun;
133(1):89-99.
PMID: 31226687
Objective: Glioblastoma (GBM) carries a high economic burden for patients and caregivers, much of which is associated with initial surgery. The authors investigated the impact of insurance status on the...
16.
Dalle Ore C, Chandra A, Rick J, Lau D, Shahin M, Nguyen A, et al.
Neurosurgery
. 2018 Nov;
85(6):793-800.
PMID: 30445646
Background: Resection may be appropriate for select patients with recurrent glioblastoma. The incidence of histopathological findings related to prior treatment and their prognostic implications are incompletely characterized. Objective: To quantify...
17.
Chandra A, Rick J, Dalle Ore C, Lau D, Nguyen A, Carrera D, et al.
Neurosurg Focus
. 2018 Jun;
44(6):E16.
PMID: 29852776
OBJECTIVE Glioblastoma (GBM) is an aggressive brain malignancy with a short overall patient survival, yet there remains significant heterogeneity in outcomes. Although access to health care has previously been linked...